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ABSTRACT
Paracoccidioidomycosis (PCM) or South American Blastomycosis is a systemic fungal infection 
caused by a dimorphic fungus, Paracoccidioides brasiliensis. It represents the most important sys-
temic mycosis in South America and with higher prevalence among male inhabitants of the rural 
area. PCM usually affects the lungs, and rarely the intestines. The authors report three cases of PCM, 
treated at the University Hospital of Universidade Federal de Mato Grosso do Sul whose scintigraphy 
with technetium-99 labeled human albumin revead intestinal protein loss.
Keywords: radionuclide imaging; paracoccidioidomycosis; intestinal diseases; Technetium Tc99m 
aggregated albumin.
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INTRODUCTION
Paracoccidioidomycosis (PCM), also known as 
South American Blastomycosis or Lutz-Splen-
dore-Almeida disease, is a systemic mycosis 
caused by the dimorphic fungus Paracoccidi-
oides brasiliensis. It is the most important deep 
mycosis in Latin America with 80% of the cases 
occurring in Brazil. In this country, the disease 
is endemic in the Southeast, South and Midwest 
regions, in humid areas with temperate climate, 
rainy summers, and acidic soil.1-4
As the PCM is not a disease that requires 
compulsory notifi cation, its actual prevalence is 
unknown. The annual rate of incidence among 
the Brazilian population has been estimated at 
1-3 per 100,000 inhabitants and the mortality 
rate, at 0.15 per 100,000 inhabitants.4 Most af-
fected individuals (90%) are males, in the age 
range of 30 to 59 years.3,5
Initially, it was hypothesized that the fungus 
entered the human host through the skin, mucosa 
and gastrointestinal tract.6-8 It is now established 
that the disease is acquired through inhalation of 
conidia, with subsequent pulmonary infection.5 
In the adult-type disease (chronic form), there 
might be pulmonary involvement, in addition to 
ulcerated lesions of the skin and mucosa (oral, 
nasal and gastrointestinal). In children or ado-
lescents, PCM presents as uncommon acute/su-
bacute form, known as the juvenile type, mostly 
affecting the phagocytic-mononuclear system, 
involving the lymphatic ganglia, spleen and liver 
and leading to bone marrow dysfunction.3,5,9 
The intestinal involvement in PCM can af-
fect the mucosa, submucosa and lymphatic-
abdominal system and is more frequently seen 
in the acute/subacute form. All segments can 
be involved, but predominantly affects the jeju-
num, ileum and proximal portion of the large 
intestine. Mesenteric ganglion infarction with 
lymphatic stasis and lymph reﬂ ux towards the 
intestinal lumen were observed in the small 
and large intestine, leading to an exudative 
enteropathy.10-13
In general, the patient with enteropathy 
due to PCM presents weight loss, malnutrition, 
adynamia, abdominal pain, diarrhea and some-
times a palpable abdominal mass.6,14 Hypoalbu-
minemia can be severe.13 
The objective of the present study was to re-
port three cases of PCM in which intestinal pro-
tein loss was identifi ed through a scintigraphy 
with technetium-99 labeled human albumin. 
PATIENTS AND METHODS
The research project called “Clinical Evolution 
of Paracoccidioidomycosis” was conducted 
at the Service of Infectious and Parasitic Dis-
Este é um artigo Open Access sob a licença de CC BY-NC-ND
541Braz J Infect Dis 2010; 14(5):540-543
eases of Hospital Universitário da Universidade Federal de 
Mato Grosso do Sul (UFMS) a state center of reference for the 
treatment of systemic mycoses. The study was approved by 
the Committee of Ethics in Research with human subjects of 
UFMS and the participants that agreed to participate signed an 
informed consent form. Epidemiological, clinical and labora-
tory data of the patients with a confi rmed diagnosis of PCM 
were collected during medical consultations. The three patients 
selected for this case report presented severe hypoalbuminemia 
with no other apparent loss pathways. They were submitted to 
scintigraphy in an Elcint scintillation chamber, model SP6-HR, 
immediately after the intravenous infusion of technetium-99-
labeled human serum albumin (HSA – Tc99m). The radioiso-
tope was prepared according to the manufacturer’s instructions 
(IPEN) and the infused dose was 740 MBq. The study consisted 
of two phases, one with dynamic and the other with static im-
ages. The dynamic images were acquired in the anterior view of 
the abdomen, immediately after the administration of the radio-
isotope, with sequential 30-second acquisitions, for 45 minutes. 
The static images were acquired in the anterior and poste-
rior views of the abdomen, with 700,000 counts, 1, 2, 3, 4, 5 and 
24 hours after the radioisotope injection. 
The HAS- Tc99m radiotracer presents a uniform distribution 
in the vascular compartments, being slowly removed from the 
bloodstream by Kupffer cells from the reticuloendothelial sys-
tem, so that 75% to 90% of the dose is captured by the liver, 3 to 
10% by the spleen and the remainder accumulates in the bone 
marrow. Hence, the lumen of the intestinal loops is not part of 
the normal biokinetics of the radioisotope and, therefore, the 
radioactive activity in the topography of the intestinal loops 
was considered a positive fi nding for enteric protein loss. 
CASE REPORTS
Case 1
A 53-year-old male individual, who was a 45-year-old rural 
worker from the state of Mato Grosso do Sul, had a diagnosis of 
PCM in 2001. At the time of the diagnosis, he presented evening 
fever, weight loss and palpable and painful non-adhered lymph 
nodes in the axillary and anterior, posterior and lateral cervical 
regions, with fi broelastic consistency, no inﬂ ammatory signs 
and size varying from 0.5 cm to 3 cm. The liver was palpable at 
3 cm from the right costal border and the pulmonary and 
cardiac systems were normal. A lymph node biopsy was per-
formed, of which histological assessment showed to be posi-
tive for PCM; yeast-like structures stemming from giant cells 
characteristic of Paracoccidioides brasiliensis were observed. 
At the time, the chest X-ray was normal and he presented se-
rum albumin level of 2.60 g%. Treatment with a combination 
of trimethoprim/sulfamethoxazole (TMP-SMX) was started; 
however, as the patient presented a skin rash, it was substituted 
by itraconazole, used irregularly by the patient. He was lost to 
follow-up as soon as clinical improvement was obtained. 
He returned after three years with a weight loss of 6 kg 
and ulcerative lesion of the nose. Serology for PCM, by radial 
immunodiffusion, was 1:512 and itraconazole 200 mg a day 
was prescribed. The patient presented initial improvement 
and did not return to the Service. Two years later, he returned 
with productive cough, fever, weight loss and adynamia. He 
presented hoarseness and a moriform lesion in the soft pal-
ate. TMP-SMX was prescribed, but there was little clinical im-
provement. The patient started to present a cramp-like diffuse 
abdominal pain, accompanied by aqueous diarrhea. At physical 
examination, he presented pallor 3+/4+, with painful abdomen 
at diffuse palpation, ascites, and lower-limb edema 1+/4+. X-
ray assessment disclosed diffuse nodular interstitial infi ltrate. 
He was submitted to bronchoscopy, that resulted normal and 
AFB and fungus cultures and screening in the bronchialalveo-
lar lavage were negative. He was anemic (hemoglobin = 9.8%) 
and erythrocyte sedimentation rate (ESR) was 40 mm/h. An 
albumin level of 0.7 g/dL showed signifi cant hypoalbumine-
mia. He was treated empirically for TB with rifampicin and 
isoniazide and received pyrazinamide and Amphotericin B for 
PCM, which resulted in the improvement in the medical con-
dition after a two-week treatment, although the albuminemia 
did not show normalization. 
The evolution coursed with the disappearance of the pal-
ate lesions, improvement in the fever, coughing and weight 
loss. There was a decrease in the levels of antibodies in the 
immunodiffusion for PCM, characterizing clinical remis-
sion of the disease. After 7 years of disease evolution and 2 
years of regular follow-up, the patient was apparently cured, 
but presented hypoalbuminemia. The intestinal scintigra-
phy showed enteric protein loss, probably originating in the 
large intestine (Figure 1).
Figure 1: Scintigraphy with technetium-99 labeled human 
albumin, disclosing enteric protein loss, probably originating 
in the large intestine.
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Case 2
ED, a 36-year-old Elementary School female teacher, na-
tive Brazilian from the Indian reserve located in the town 
of Nioaque state of Mato Grosso do Sul, had a diagnosis 
of acute/subacute form of PCM when she was 15 years 
old. In 1990, the clinical examination showed muriform 
lesions in the oral mucosa and cervical lymphadenom-
egaly. The lymph nodes were fibroelastic and not tender 
with the largest measuring 2 cm. She did not present liver 
or spleen enlargement and the chest X-ray was normal. 
Brush biopsy of oral lesions disclosed Paracoccidioides 
brasiliensis. Serological result (immunodiffusion) was 
1:64. The patient received TMP-SMX for two years and 
remission was achieved. 
A few months later after treatment withdrawal, in 1992, 
she relapsed and was admitted to the hospital presenting 
fever, weight loss, cervical lymph node enlargement, bi-
lateral axillary lymphadenomegaly, hepatosplenomegaly, 
and jaundice. Treatment was initiated with Amphotericin 
B. During hospitalization the patient developed ascites 
and abdominal pain, but was released 60 days thereafter 
to followed-up as an outpatient. At the last assessment in 
2009, the ultrasound scan showed a decrease in liver size, 
with diffusely heterogeneous and irregular echotexture, 
slightly dilated portal vein with a mean caliber of 1.3 cm 
and a slight splenomegaly, suggesting liver cirrhosis with 
slight portal hypertension. Aminotransferase levels were 
normal and serologies for hepatitis B and C were negative. 
Serum albumin had decreased and to 1.8 g/dL (reference 
values: 3.4 to 4.8 g/dL). In relation to possible cause of hy-
poalbuminemia, 24-hour proteinuria was normal, as well 
as liver function tests. An intestinal scintigraphy was then 
performed with technetium-99 labeled human albumin, 
which demosnstrated protein loss at the colon. 
Case 3
JFM, a 50-year-old male auto mechanic from the town 
of Terenos, state of Mato Grosso do Sul, was diagnosed 
with the acute/subacute form of PCM when he was 25 
years old. In 1984 he sought our Service after experienc-
ing weight loss (9 kg), fever and multiform lesions in the 
gingiva and soft palate, as well as generalized adenom-
egaly (cervical, epitrochlear, axillary and inguinal sites). 
The patient complained of abdominal colic-like pain. At 
physical examination, he presented hepatomegaly 3 cm 
from the right costal border. Chest X-ray was normal. 
Lymph node biopsy followed by histological analysis re-
vealed P. brasiliensis. The serology result was 1:32. The 
patient underwent a radiological assessment of intestinal 
transit, which disclosed an irregular aspect of the mucous 
intestinal folding pattern, with thickened and discrete 
folds. Localized intestinal narrowing was also observed. 
The patient was treated with Amphotericin B. In 1994, 
he relapsed, with cervical adenomegaly and jaundice. The 
ultrasonography scan showed a liver with heterogeneous 
aspect. Treatment with TMP-SMX was initiated followed 
by clinical remission. 
At the last assessment, in 2009, he complained of limb 
edema; serum albumin was 1.8 g/dL. Liver function and 24-
hour urinary protein tests were normal. A scintigraphy with 
technetium-99 labeled human albumin was performed, 
which disclosed slight protein loss in the small intestine.
DISCUSSION
The three reported cases are of acute/subacute PCM or ju-
venile type, in which the phagocytic-mononuclear system is 
affected, involving all lymphatic glands and also the liver in 
the second and third cases. Intestinal involvement is more 
prevailing in the acute/subacute form, consequent to the 
involvement of the abdominal/lymphatic system.6,8 All pa-
tients had been previously treated with clinical remission of 
the disease. 
Persistence of abdominal lymphatic vessel obstruction 
has been observed even in treated cases. The established 
fi brosis impairs the lymphatic circulation, causing lym-
phangiectasia, with lymph reﬂ ux to the intestinal lumen, 
which has been demonstrated by other studies.3,5,9
In the assessed patients, the reported digestive com-
plaints were abdominal pain and diarrhea. Digestive com-
plaints are observed in over 50% of PCM cases: sialorrhea, 
dysphagia, halitosis, abdominal pain, gastric plenitude, py-
rosis and intestinal motility alterations and, less commonly, 
regurgitation, vomiting, hiccups and the presence of ab-
dominal mass.15
The most often affected segments of the gastrointestinal 
tract are the ileum, stomach, duodenum, jejunum, ascending 
and descending colon. The functional alterations (hyperse-
cretion, hypotonia and decreased peristaltism) are more fre-
quent than organic abnormal fi ndings (intestinal fold thick-
ening – verifi ed in case 3 through radiological assessment of 
intestinal transit – stenosis, dilation, extrinsic compression 
by the liver, spleen or lymph nodes and rigidity).15 
Intestinal involvement in PCM is present in 2.7% to 
28.4% on autopsy.10 There can be intestinal absorption im-
pairment of proteins, glucose and, predominantly, fat due 
to the obstruction of lymphatic pathways. Malabsorption is 
confi rmed through studies of D-xylose absorption and the 
fecal excretion of fat or labeled albumin.15 The abdominal 
involvement can also be demonstrated by examinations such 
as intestinal transit, abdominal tomography and colonosco-
py. Lesions can occur throughout the small intestine, with 
consequent acceleration of the intestinal transit, in addition 
to mucosal hypersecretion and disabsorptive pattern. There 
is also a predominance of lesions in the terminal ileum, ap-
pendix and right hemicolon. In the large intestine predomi-
nates mucosal irregularities, followed by loss of haustrations 
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interwoven by segmental regions and several stenoses with 
smooth and regular borders, which at more advanced phases 
and as a consequence of treatment, become more pronounced 
due to scarring and fi brosis.16 
Mesenteric lymph node infarction can be observed in 
both large and small intestine, with lymphatic stasis and 
lymph reﬂ ux towards the intestinal lumen, thus establishing 
exudative enteropathy.10-13
In the reported cases, the intestinal albumin loss was 
demonstrated by the scintigraphic method. The study us-
ing chromium-51 – labeled albumin in patients with PCM 
showed a correlation between the intensity of fecal excretion 
of radioactivity and levels of serum albumin, lymphopenia 
and presence of fecal fat.17 
Some authors have used technetium-99 labeled human al-
bumin scintigraphy studies to identify loss of protein through 
the intestine caused by other etiologies as a qualitative method, 
as it shows where in the intestine the protein loss occurs. The 
test is performed in a few hours, with no need for previous 
preparation or stool collection. It can be used in enteropathy 
with protein loss due to diseases such as Cröhn’s disease, ile-
ocecal tuberculosis and ulcerative colitis. False-positive results 
can occur in the presence of active intestinal bleeding.18,19 
At the scintigraphy, cases one and two showed involve-
ment of the large intestine due to PCM as the cause of protein 
loss and of the small intestine in case three. 
The use of scintigraphy with technetium-99 labeled hu-
man albumin to demonstrate intestinal protein loss in PCM 
has been scarcely reported in the literature. A recent study 
involving ten patients with acute/subacute form disclosed 
intestinal protein loss in all patients at the time of diagnosis 
and persistence of the loss years after the treatment in three of 
them, which demonstrates the importance of the method in 
the clinical management of these patients.20 
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